We manufacture and sell rehabilitation devices using virtual reality that provide measurements useful for diagnosis and treatment, or that are used to evaluate task achievement levels.
[画像1: https://prtimes.jp/i/51411/7/resize/d51411-7-a7fc87a7ae2386bee63c-2.jpg ] 株式会社mediVR(本社:大阪府豊中市)の代表取締役であり医師の原正彦が筆頭著者を務める論文が、米国神経学会(American...
[画像1: https://prtimes.jp/i/51411/6/resize/d51411-6-f404edece16e1f91d15a-0.jpg ] 仮想現実(VR)技術を活用したリハビリテーション用医療機器「mediVRカグラ」を製造販売する株式会社mediVR(メディブイア...
  [画像1: https://prtimes.jp/i/51411/5/resize/d51411-5-2beb47e52026a447b4e4-2.png ] 「知財功労賞」は、知的財産権制度の発展及び普及・啓発に貢献した個人ならびに制度を有効に活用し円滑な運営...
  [画像1: https://prtimes.jp/i/51411/3/resize/d51411-3-9737973811e2492a64fa-0.jpg ] ■開設の背景 これまでリハビリ業界では、「治療の成果にかかわらず、リハビリを提供した時間・労力に対し対価...

At Beef Sommelier, we provide our B-som Diagnosis with the aim of creating a world where producers can raise their ideal cattle and consumers can enjoy beef that truly matches their preferences. Our technology not only quantifies biological information from beef cattle, but also supports producers in achieving their target meat quality. By introducing a new scientific perspective that goes beyond conventional standards, we make the “unseen qualities” of beef visible and measurable. This enables consumers to clearly understand the characteristics of the beef they choose. B-som is the world’s first scientific diagnostic service that bridges the gap between producers and consumers.

A Kyoto-based startup has developed the world's first cell therapy enabling nerve regeneration using ES/iPS cell-derived Schwann cells. This breakthrough enables large-scale production of cells previously difficult to mass-produce, paving the way for clinical trials.

Visualizing the mind and body to spark behavioral change. Evcare is dedicated to advancing human well-being through cutting-edge hormone measurement technology derived from academic research. We specialize in analyzing biomarkers found in hair, nails, and saliva. Our core services include: R&D Support: Accelerating product development with scientific evidence. Corporate Wellness: Providing objective stress checks based on physiological data, moving beyond subjective surveys to true health visualization.

We are conducting clinical development of an oral therapeutic cancer vaccine. We have completed a Phase I clinical trial targeting urothelial carcinoma and are currently conducting a Phase I/IIa clinical trial for malignant pleural mesothelioma.